A detailed history of Bessemer Group Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 140 shares of VIR stock, worth $1,033. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140
Holding current value
$1,033
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.26 - $10.7 $1,016 - $1,498
140 New
140 $1,000
Q2 2023

Aug 10, 2023

BUY
$23.2 - $27.29 $1,484 - $1,746
64 New
64 $2,000
Q3 2022

Nov 09, 2022

BUY
$18.26 - $31.1 $2,556 - $4,354
140 New
140 $3,000
Q4 2020

Feb 09, 2021

BUY
$25.51 - $43.38 $0 - $0
0 New
0 $0

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $979M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.